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A B S T R A C T  The neurointermediate  lobes of dark-adapted  toads Xenopus laevis 
were  incubated  for 30  rain  in  [aH]arginine  and  then  "chased"  for various  time 
periods. By use of this pulse-chase paradigm there were detected 10 trichloroacetic 
acid (TCA)-precipitable peptides separated on acid-urea polyacrylamide gels and 
one TCA-soluble peptide separated by high-voltage electrophoresis (pH 4.9)  with 
melanotropic activity. Each of these peptides had a different degree of melanocyte 
stimulating hormone (MSH) activity as revealed by the Anolis skin bioassay. Three 
of these TCA-precipitable peptides comigrated with ACTH, fl-lipotrophin, and ot- 
MSH on acid-urea gels. Evidence suggesting a precursor-product mode of biosyn- 
thesis  of the  melanotropic peptides  is  presented.  7  of the  10  TCA-precipitable 
peptides and the one TCA-soluble peptide with melanotropic activity were released 
into the medium. The half-time of release of the TCA-precipitable peptides was 
about 2 h, whereas the half-time of TCA-soluble peptide release was about 30 min. 
The release of these peptides was inhibited by 5  x  10  -5 M dopamine.  Dopamine 
inhibition of release did not appear to affect the biosynthesis of the melanotropic 
peptides,  but  did  appear to enhance  the  degradation  of the  newly  synthesized 
TCA-soluble peptide in the tissue. White adaptation of the toads greatly decreased 
the biosynthesis of all of the TCA-precipitable melanotropic peptides. 
INTRODUCTION 
Several types of melanotropic peptides have been found in the pars intermedia 
of lower vertebrates and mammals (Burgers,  1963;  Preslock and Brinkley, 1970; 
Hopkins,  1972;  Baker,  1973).  These  peptides,  including  a-  and  #-melanocyte 
stimulating hormone  (MSH),  all contain  a  heptapeptide  amino acid sequence, 
-Met-Glu-His-Phe-Arg-Trp-Gly-, which appears to be the "active core" essential 
for melanotropic activity (i.e. to cause the expansion of melanocytes) (Eberle and 
Schwyzer, 1975). Adrenocorticotrophic hormone (ACTH) and fl-lipotrophin (/3- 
LPH) also are found in the pars intermedia,  possess melanotropic activity, and 
contain  this heptapeptide  sequence.  Indeed,  it has been  proposed that ACTH 
and  ~-LPH  are  the  precursors  of  or-  and  /3-MSH,  respectively,  in  the  pars 
intermedia  (Scott  et  al.,  1973;  Lowry and  Scott,  1975;  Bradbury  et  al.,  1976). 
Although the biosynthesis of both ACTH and a-MSH has recently been demon- 
strated  in  the  rat  neurointermediate  lobe (Scott et al.,  1976),  systematic pulse- 
THE  JOURNAL  OF  GENERAL PHYSIOLOGY " VOLUME  70,  1977  "  pages  37-58  37 38  THE JOURNAL  OF  GENERAL  PHYSIOLOGY •  VOLUME  70  -  1977 
chase experiments showing the conversion of ACTH to ct-MSH in situ have not 
been done. 
Another significant question relates to the mechanism of control of release 
and  biosynthesis  of the  melanotropic  peptides.  Morphological  studies  have 
shown  that  two  types  of  nerve  fibers  from  the  hypothalamus end  on  the 
secretory cells in the pars intermedia: one type contains electron-dense catechol- 
aminergic vesicles, and the other contains large neurosecretory granules pre- 
sumed to be  peptidergic  (Dawson,  1953; Etkin,  1962; Iturriza,  1964; Saland, 
1968;  Nakai and  Gorbman,  1969; Hopkins,  1971). Although there  have been 
proposals that hypothalamic peptides, i.e. melanocyte-stimulating hormone re- 
leasing factor (MSH-RH) and melanocyte inhibitory factor (MIF) may regulate 
MSH release (Taleisnik and Orias,  1965; Taleisnik and Tomatis,  1967; Kastin 
and  Schally,  1966; Celis  et  al.,  1971) there  have  also  been  extensive  studies 
showing that MSH release is under hypothalamic inhibitory control by catechol- 
amines (Iturriza and Kasal-Iturriza, 1972; Hadley et al., 1973, 1975; Bower et al., 
1974; Olsson and Gorbman, 1973; Baker, 1976). A morphological-histochemical 
study by Terlou and his co-workers (Terlou and Van Straaten, 1973; Terlou and 
Van Kooten, 1974), concluded that the MSH-producing cells are under mono- 
aminergic  control.  The  catecholamine in Xenopus  pars  intermedia  has  been 
identified as dopamine (Terlou and Van Kooten, 1974). The results of various 
pharmacological studies (Tanzer and Thoenen, 1968; Smith, 1975; DeVolcanes 
and Weatherhead, 1976) have lent support to the hypothesis that the release of 
MSH is under inhibitory control by dopamine. The effect of dopamine to inhibit 
release raises the question of whether there is an inhibition of the biosynthesis of 
MSH by dopamine. Studies by Thornton (1974) suggested that there was no such 
effect of dopamine on phenylalanine incorporation into the toad neurointerme- 
diate lobe; however, direct evidence on the effect of dopamine on MSH synthe- 
sis is lacking. 
The first part of this paper describes our studies on the heterogeneity and 
biosynthesis of melanotropic  peptides  in  the  neurointermediate lobe  of the 
South African clawed  toad Xenopus  laevis.  Some  evidence is  presented,  from 
"pulse-chase" labeling studies, suggestive of a  precursor-product mode of bio- 
synthesis of the melanotropic peptides. The second part considers the mecha- 
nisms and time courses of release of the melanotropic peptides, their identifica- 
tion  and  correlation with the  peptides  synthesized in  the  neurointermediate 
lobe, and the regulation of the biosynthesis and release of these  peptides by 
dopamine. 
MATERIALS  AND  METHODS 
Animals 
Adult toads (Xenopus laevis) weighing 40-70 g were obtained from Amphibian  Facilities, 
Ann Arbor, Mich., and maintained in plastic aquaria at 22°C. Before use in experiments, 
the animals were  placed on either a white (white-adapted)  or a black (dark-adapted) 
background for 7-15 days. Except where otherwise indicated, dark-adapted animals were 
used for the biosynthesis experiments and white-adapted  animals were used  for the 
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Incubation of Neurointermediate Lobes in [3H]Arginine 
Neurointermediate  lobes were  dissected  from  the  toads  and  preincubated  at  22°C  in 
amphibian Ringer (NaC1, 112 mM; KCI, 2 raM; CaCI2, 2 raM; HEPES,  15 raM; glucose, 5 
mg/ml;  bovine serum albumin,  1 mg/ml;  ascorbic acid,  1 mg/liter; pH 7.35)  for 1 h  to 
maximize melanotropic peptide biosynthesis in vitro (Hopkins, 1970).  The neurointerme- 
diate lobes were then "pulse" incubated in the presence of 17.5  /xM [3H]arginine (New 
England Nuclear, Boston, Mass., sp act =  28.7 Ci/mmol) for 30 rain. After the "pulse," the 
neurointermediate lobes were either homogenized immediately in 0.1 N  HCI or "chased" 
in  amphibian  Ringer  in  the  presence  of unlabeled arginine  (1  raM)  for  varying time 
periods  before  homogenization  in  0.1  N  HC1.  For  the  studies  on  the  regulation  of 
biosynthesis and the release of MSH, 5  ×  10  -5 M dopamine (the concentration found to 
be effective in inhibiting MSH release [Bower et al., 1974]) was included in the pulse and/ 
or chase medium. The chase medium was analyzed for melanotropic peptide released in 
the  presence  and  absence of dopamine.  After the  incubation,  HCI  was  added  to  the 
medium to a  final concentration of 0.1  N. 
Preparation of the Tissue Homogenate  and Medium for Analysis 
The above homogenate (or medium sample) was heated at 100°C for 10 rain, and 50/zg of 
bovine serum albumin was added to the solution as carrier. Proteins in the homogenates 
and media samples were then precipitated by cold 10% trichloroacetic acid (TCA). The 
TCA-precipitable fractions were separated from the TCA-soluble fractions by centrifuga- 
tion at 12,000 g  for 5 rain in a  Beckman microfuge (Beckman Instruments, Inc., Spinco 
Div.,  Palo Alto, Calif.). TCA was removed  by extensive washing of both  fractions with 
ether. The TCA-soluble peptides were then passed through a copper Sephadex column 
(Fazakerly and Best, 1965) to remove the unincorporated [3H]arginine. This was followed 
by gel filtration on  a  Sephadex GI0 column  (using 5%  acetic acid as the eluant).  The 
excluded volume (VE) and the included volume (VI, <700 daltons) of the Sephadex G10 
were then collected for analysis. 
Analysis of the TCA-Precipitable Peptides 
The TCA-precipitated pellet from tissue or medium was dissolved in 50/xl of 0.9 M acetic 
acid in 5 M urea. A 5-/xl sample was then taken for radioactive counting. The remainder 
of the sample was analyzed by electrophoresis on 11% acid-urea, polyacrylamide (11 cm × 
4 ram) cylindrical gels (Davis et al., 1972).  5/~g of cytochrome c was included in the sample 
as an internal standard marker. The run was terminated when the cytochrome c ran 5 cm. 
Gels were  stained with Coomassie blue, destained, and  sliced into  1.5-ram slices. Each 
slice was eluted in scintillation cocktail and counted for its radioactivity in a Beckman LS 
330 scintillation counter. Details of the gel electrophoresis and counting procedures have 
been described elsewhere (Loh  and  Gainer,  1975).  When the molecular weights of the 
TCA-precipitable peptides were  to be determined,  the labeled peptides on  unstained 
acid-urea gel were  cut  out,  and  the  peptides were  eluted  and  re-electrophoresed on 
polyacrylamide gels  in  sodium  dodecyl  sulfate  (SDS).  Details regarding  the  SDS  gel 
electrophoresis procedures have been previously reported (Gainer, 1971). 
Analysis of TCA-Soluble Peptides 
A sample of the TCA-soluble peptides from the V  E and 1I[ of the G10 run was taken for 
radioactive counting and the remainder was lyophylized and resuspended in 20/zl of 5% 
acetic acid in methanol. This sample was then spotted on thin layer cellulose plates (250 
/~m)  and separated by high-voltage electrophoresis with a  pH 4.9 buffer (glacial acetic 
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electrophoretic run. At the end of the run, the plates were air dried and scraped into l- 
cm segments for analysis  of their radioactivity. 
Bioassay of Melanotropic Peptides 
For the bioassay experiments, neurointermediate lobes from white-adapted toads known 
to store MSH granules (Hopkins,  1970) were used. The lobes were homogenized and 
treated as described above. TCA-precipitable peptides were eluted from 1.5-cm slices of 
the acid-urea gel after electrophoresis and bioassayed. TCA-soluhle peptides were eluted 
from the  cellulose plates  (1-cm  segments) after high-voltage electrophoresis. Peptides 
were eluted with Anolis medium and melanotropic activity was determined with the Anolis 
skin bioassay as described by Tilders et al. (1975). This method has been shown to be very 
sensitive and specific for MSH and  related  molecules. Specimens of Anolis carolinensis 
were obtained from Mogul-Ed Corp., Oshkosh, Wis.). 
RESULTS 
IncortJoration of [3H]Arginine into Neurointermediate Lobe Peptides 
Comparison of the [aH]arginine incorporation into TCA-precipitable  peptides 
in  the neurointermediate lobe from white-adapted  and  dark-adapted  toads  is 
illustrated  in  Fig.  1.  Dark-adapted  lobes  exhibited  a  linear  incorporation  of 
[SH]arginine with time, from 5 to 150 min of incubation (Fig. I, filled circles). In 
contrast,  lobes  from white-adapted  animals  appeared  to be nonlinear in their 
incorporation of [nH]arginine (Fig. 1, open circles). After 30 rain of incubation in 
[SH]arginine, the TCA-precipitable radioactivity in dark-adapted lobes was five- 
fold greater than in white-adapted lobes. After 150 rain of incubation, the ratio 
of radioactivity between the lobes fell to about 2.5. The increased incorporation 
rates in the lobes of the dark-adapted vs. white-adapted animals  are consistent 
with the well-known metabolic responses of this gland to enhance MSH synthesis 
and release under dark-adapting conditions (Hopkins,  1970;  Thornton,  1974). 
Neurointermediate lobes of dark-adapted animals were used in the pulse-chase 
experiments described below. The arginine chase data illustrated in Fig. 1 (filled 
squares, broken line) show that a  chase in  1 mM unlabeled arginine after a  30 
rain incubation in [3H]arginine effectively prevented any further incorporation 
of [SH]arginine into TCA-precipitable peptides. 
Evidence for the Processing of Newly Synthesized Polypeptides in the Neurointerme- 
diate Lobe 
Fig.  2  illustrates  the labeling  patterns  of TCA-precipitable  peptides  extracted 
from neurointermediate lobes which had been pulse incubated in [SH]arginine 
for 5,  15, and 30 rain and separated by electrophoresis on acid-urea gels.  In all 
three cases, the same labeled peak (designated a) dominates the profile, and no 
consistent  qualitative  differences  in  profile  could  be  determined.  Peak  i  is 
inconsistently seen in  pulse experiments and therefore cannot be considered a 
significant difference between the 30-rain and 5-rain pulse profiles. Peak a  also 
appears to be synthesized in white-adapted lobes (Fig. 2) although at much lower 
levels. Because of the similarities in profile between the 5-rain and 30-rain pulses, 
all  subsequent  pulse-chase  experiments  were  done  by  use  of  30-rain  pulse 
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The fates of the peptides synthesized during a 30-min pulse were examined by 
chase incubations of the pulsed lobes for durations ranging from 15 min to 180 
min. The results of these experiments are depicted in Fig. 3. After the 30-min 
pulse,  peak  a  (Fig.  3,  upper  left  panel)  contained  about  30%  of  the  total 
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FIGuaE  1.  Time course of incorporation of [3H]arginine into TCA-precipitable 
peptides  by  neurointermediate  lobes of dark-adapted  and  white-adapted  toads. 
The  ordinate  shows  the  TCA-precipitable cpm  per gland,  and  the  abscissa the 
period  (in  minutes)  of incubation.  Note  that  the  incorportion  in  dark-adapted 
animals (solid circles) is linear for 150 min and approximately five times greater 
than for white-adapted animals (open circles) in the first 30 min. The incorporation 
into the white-adapted animals appears to be nonlinear, with the slope increasing 
significantly after 60 rain. When the lobes were chased in unlabeled arginine after a 
30-min pulse in [SH]arginine, the further incorporation of [SH]arginine was com- 
pletely inhibited, as shown by the dotted line (solid squares). The inset in the upper 
left corner shows the change in the animal's color after 2 wk of adaptation to a black 
or white background. 
radioactivity on the acid-urea gel.  In the subsequent chase periods (Fig. 3,  15- 
180  rain)  peak a  progressively decreased in radioactivity concurrently  with the 
emergence of several new labeled peaks (i.e. peaks b-j).  After prolonged chase 
incubations  (60-180  rain),  peak a  was greatly decreased  and peak c  now domi- 
nated  the  profile.  Significant  radioactivity  was  also  present  in  peak  e.  The 42  THE  JOURNAL  OF  GENERA  L  PHYSIOLOGY' VOLUME  70"  1977 
labeling profiles in  Fig.  3 are suggestive of a  processing of a  larger precursor 
(peak a) to peptide products (peaks b-j) with time in the neurointermediate lobe. 
This suggestion  is  supported  by the  molecular weight  analyses of the  various 
peaks (Table I) discussed below. Since so many labeled peptides appear during 
the chase, it is not possible at present to describe the specific processing sequence. 
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FIGURE 2.  Acid-urea gel labeling profiles of TCA-precipitable peptides of neuroin- 
termediate lobes after 5-, 15-, and 30-rain pulses in [3H]arginine using neurointer- 
mediate lobes from dark-adapted toads and a 30-rain pulse of lobes from white- 
adapted animals. The ordinate shows the cpm/gel slice,  and the abscissa  the slice 
number. Peak a is the dominant peak in all the profiles. 
This is further complicated by the appearances of peaks k and I after prolonged 
chases, since these peptides are clearly of higher molecular weight than peak a. 
Characterization and Identification  of the Labeled Peaks 
Table I  summarizes the Rf values of the various peaks seen in Fig. 3 (Rf equals 
the  mobility  relative  to  cytochrome c  on  acid-urea  gels)  and  the  molecular 
weights of some of these peaks as evaluated by electrophoresis on SDS gels. The 
molecular weight of peak a  was  36,000  daltons.  Since  peaks b-j are clearly of 
lower molecular weight, these data are consistent with the notion of a precursor- 
product relationship between the polypeptide(s) represented by peak a  and the LOH  AND  GAINER  Melanotropic  Peptide  Biosynthesis and Release  43 
20 
16 
12 
28 
UJ 
=  24 
< 
I-- 
o 
~-  8 
4 
20 
16 
12 
8 
4 
30 rain  pulse 
30 rain pulse - 15 min chase 
c 
f 
P~  ..... 
30 rain pulse - 60 min chase 
c 
¢ 
 Ad 
e, 
1~,¢¢  ?  h  j 
30 rain pulse - 120 rain chase 
c 
10 
a  30 min pulse - 30 rnin chase 
c 
l 
20  30  40  50 
30 rain pulse - 180 min chase 
c 
a  ~e 
60  10  20  30  40  50  '  ¢0 
SLICE NUMBER 
FIGURE 3.  Acid-urea  gel  labeling  profiles  from  pulse-chase  experiments  with 
neurointermediate  lobes  from  dark-adapted  animals.  Each  lobe  was  pulsed  in 
[aH]arginine for 30 min and chased in unlabeled arginine for various times (ranging 
from 0 to  180 rain). Only TCA-precipitable peptides were electrophoresed. The 
ordinate shows the percent total cpm on the gel/gel slice, and the abscissa shows the 
slice number (see text for details). 
smaller peptides. Several of the labeled peaks comigrated on acid-urea gels with 
certain known melanotropic peptides. Purified/3-LPH,  ACTH,  fl-MSH, and ct- 
MSH had been found in preliminary experiments to be TCA precipitable and 
had Rf values equal to 1.01  -  0.01 (peak g), 1.30 +- 0.02 (peak i), 1.60 +- 0.02, and 
1.72 -  0.02 (peak  j), respectively. In addition, the estimated molecular weights of 
peak g and peak i (Table I) compare favorably with the known molecular weights 44  THE  JOURNAL  or  GENERAL  PHYSIOLOGY" VOLUME  70"  1977 
of/3-LPH and ACTH,  respectively. On the basis of these correlations and the 
fact that all of these peaks are released by the neurointermediate lobe and have 
potent melanotropic activity, we suggest that the toad  pars intermedia synthe- 
sizes, stores, and releases/3-LPH, ACTH,  and a-MSH. Although there is some 
melanotropic activity on the gels with an Rt equal to 1.6 (i.e. corresponding to/3- 
MSH), we have not detected a  labeled peak in this region of the gel. In addition 
to  these  tentatively identifiable peaks,  the  toad  neurointermediate  lobe  also 
synthesizes and releases  at  least  four additional (unidentified) TCA-precipita- 
ble, melanotropic peptides (Table I). 
TABLE  I 
ANALYSIS OF TCA-PRECIPITABLE PEPTIDES SYNTHESIZED IN  THE 
NEUROINTERMEDIATE LOBE  OF THE TOAD* 
Bioassayable§ mela- 
Labeled peak  Rf (acid.urea gels)  Molecular weight  Released:~  notropic activity 
a  0.46---0.02  (23)  36,000-+2,500  (3)  0  ++ 
b  0.58-+-.0.01  (12)  21,000"1,400  (2)  0  0 
c  0.65---0.02  (23)  18,000  (1)  +  ++ 
d  0.74+-0.03  (11)  12,000~-2,700  (3)  0  + 
e  0.83-+0.02  (13)  9,000  (1)  +  + 
f  0.91-*-0.008 (12)  14,000-+3,200  (3)  0  0 
g  1.01-+0.01  (12)  9,000-+2,300  (2)  +  +++ 
h  1.2  -+0.01  (6)  -  0  0 
i  1.31 --.0.036 (10)  4,300  (1)  +  + + + 
j  1.74-+0.03  (5)  -  +  +++ 
k  0.16-+0.006  (3)  -  +  +++ 
l  0.27-+0.01  (3)  --  +  + 
* The labeled peaks are illustrated in Figs. 2-5. Rt represents the mobility of each peak on acid-urea 
gels relative to cytochrome c. Molecular weights were determined by elution of peaks from acid-urea 
gels, and subsequent electrophoresis  on SDS gels (see Materials and Methods). Rt and molecular 
weight expressed  as means -+ SE. (The numbers in parenthesis represent the number of determina- 
tions). The R t values on acid-urea gels for B-LPH, ACTH, B-MSH, and a-MSH were 1.01 -+ 0.01, 
1.30 ± 0.02, 1.60 --- 0.02, and 1.72 --- 0.02, respectively. 
Peptides released into the medium denoted by +; not released,  denoted by 0. 
§ Bioassayable activity was determined by the Anolis assay (Tilders et al., 1975). 0 = no activity, + = 1 
Anolis unit (AU), ++ =  10 AU, +++ =  100 AU. i AU is equivalent to the melanocyte response to 
10  -t~ M synthetic a-MSH. 
Time Course and Dopamine  Control of Release of TCA-Precipitable Peptides 
The  pulse-chase  experiments  described  in  Fig.  3  showed  that  there  was  a 
redistribution of the  radioactivity into different peaks  with time.  In addition, 
there was a  slow decline of absolute TCA-precipitable radioactivity in the tissue 
simultaneous with an increase of TCA-precipitable radioactivity in the medium 
after long-term chases.  These data are illustrated in Fig. 4. The  release of the 
labeled peptides  into the  medium  appeared  to have  a  lag  time.  Release  first 
became apparent 2 h  after chase and was completed about 2 h  later (i.e. after 3-4 
h  of chase). About 30% of the total TCA-precipitable radioactivity in the tissues 
after the pulse appeared in the medium after 3 h  of chase. This lag time of 60 
min for release of TCA-precipitable peptides is consistent with the observation LoN ^NV  GAINER  Mtlanotropic  Peptide Biosynthesis and Release  45 
(in Fig. 3) that it takes about this long for the processed products (peaks c-j)  to 
appear in the tissue. 
The labeled peptides in the medium after 3 h  of chase were analyzed by acid- 
urea gel electrophoresis. The labeling profile of the TCA-precipitable peptides 
in the medium is shown in Fig. 5. Seven peaks of radioactivity (peaks c, e, g, i, j, 
k,  and l) were released (Fig. 5, filled circles) from the neurointermediate lobe, 
and  each  of  these  peaks  (Rf  values)  contained  melanotropic  activity  in  the 
bioassay  experiments  on  tissues  from  white-adapted  animals  (see  Fig.  5  and 
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FIGURE 4.  TCA-precipitable cpm in the tissue (filled circles)  and medium (open 
circles), expressed as a percent of TCA-precipitable cpm in tissue plus medium with 
time of chase (abscissa). The labeled TCA-precipitable peptides in the tissue decrease 
after 1 h of chase to a steady value at 3 h. Labeled TCA-precipitable peptides first 
appear in the medium after 1 h of chase, and approach a steady value after 3 h. 
Table  I).  Peaks g,  i, j,  and k  appeared  to have the  most  potent melanotropic 
activity. The apparent release of these peaks after synthesis may explain to some 
extent the variable presence of certain labeled peaks (such as peak i) in the tissue 
after pulse labeling. The release of these labeled peptides is completely inhibited 
if 5 ×  10  -5 M dopamine is included in the chase medium (Fig. 5, open circles). In 
the  dopamine  chase,  only a  small  amount  of the  putative  precursor,  peak a, 
appears  to have been released.  Since  dopamine  does  not  appear  to alter  the 
biosynthesis and processing steps (see discussion of Fig. 7, below) in the lobes, it 
is unlikely that the release of peak a  in dopamine chase medium was due to a 
pile-up of precursor in the cell. 
Fig. 6 shows the quantitative data relating to the dopamine inhibition. In the 46  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  "  VOLUME  70  "  1977 
control tissue, which was chased for 3 h  (open bar), 72%  +- 4% of total incorpo- 
rated  radioactivity remained  in  the  tissue  and  28%  -+  4%  was  detected  in  the 
medium. In the presence of dopamine 89%  -  4% of total incorporated radioac- 
tivity remained  in  the  tissue  and  6.3%  -+  0.8%  was recovered in the  medium. 
Thus the 5  x  10  -s M dopamine treatment results in a  78%  -  2.8% inhibition of 
release of TCA-precipitable peptides. 
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FIGURE 5.  Acid-urea gel patterns of labeled TCA-precipitable peptides in the 3-h 
chase medium in the absence (solid circles) and presence of 5 x  10  -5 M dopamine 
(open circles).  The ordinate and abscissa are as described for Fig. 2. In the control 
(nondopamine treated), 3H-labeled  peaks k, l, c, e, g, i,  andj are released.  In the 
medium from tissue  which was pulsed and chased for 3 h in dopamine, there was 
inhibition of release except for a very small amount of peak a. Each of the released 
peaks comigrates with melanocyte-stimulating bioassayable activity.  The extent of 
bioactivity  is  denoted  by (*),  where  (**)  >  (*). Bioassay  data  were  obtained  in 
experiments done on white-adapted animals. 
Lack of  Effect of Dopamine on the Biosynthesis and Processing of TCA-Precipitable 
Peptides 
The above inhibition of release of the labeled peptides by dopamine raised the 
question of whether this was due to dopamine inhibition of the biosynthesis and/ 
or processing mechanisms of the secretory cells.  To test  for these  possibilities, 
lobes from dark-adapted animals  were  preincubated  in  5  x  10  -5  M  dopamine 
and  then  pulsed  (in  [3H]arginine)  for 30  rain in  the  presence  of 5  x  10  -5  M 
dopamine (Fig. 7, filled circles). Another group of lobes were chased for 3 h  in 
dopamine after the pulse (Fig. 7, open circles). The acid-urea gel labeling profile 
after  a  30-min  pulse  in  dopamine  (Fig.  7,  filled  circles)  was  similar  to  that Loft  AND  GAINER  Melanotropic Peptide Biosynthesis and Release  47 
observed  in  experiments  in  the  absence  of dopamine  (see  Fig.  2,  and  Fig.  3, 
upper  left  panel).  Thus  there  appears  to  be  no  effect  of  dopamine  on  the 
incorporation of the [3H]arginine in these experiments.  Similarly, the results of 
the chase incubation  in dopamine  (Fig.  7, open circles)  show that there was no 
modification of the qualitative  distribution  of labeled  peaks when compared  to 
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FIGURE 6.  Bar  graphs  showing  the  effect  of  dopamine  on  the  release  of 
[aH]arginine-labeled TCA-precipitable  peptides.  In the control (open bar),  72%  + 
4% of the radioactivity remained in the tissue, and 28%  -  4% was recovered in the 
medium after a 3-h chase. With 5 ×  10 -5 M dopamine in the medium during the 3 h 
chase (striped bars) 89%  +  4% of the radioactivity remained in the tissue and 6.3% 
-+ 0.8%  was recovered in the medium, representing a 78% inhibition of release by 
dopamine. 
control  chase  experiments  (see  Fig.  3).  The  only  difference  is  the  apparent 
accumulation  of the releasable  peaks  (seen  in  Fig.  5)  in  the  dopamine-treated 
tissue (Fig.  7).  This is consistent with the observed inhibition of release of these 
peaks by  dopamine  (Figs.  5,  6).  Thus,  in  these  relatively  short-duration  treat- 
ments  of  the  lobes  with  dopamine,  there  appeared  to  be  no  effects  on  the 
biosynthesis  or processing  mechanisms  in the  tissue,  and  therefore,  the  dopa- 
mine appears  to selectively inhibit the release mechanism. 48  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUM  Ir  70 •  1977 
Time Course and Dopamine Control of Release of TCA-Soluble Peptides 
Fig. 8 shows that when neurointermediate lobes were pulsed for 30 min and then 
chased for various periods (1-4 h), there was a  rapid  decrease of TCA-soluble 
label  in  the  tissue  (solid  circles)  with  time.  The  amount  of  labeled  peptide 
recovered in the medium (open circles) reached a  maximum after 1 h  of chase. 
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FIGURE 7.  Acid-urea gel labeling patterns showing the effect of dopamine on the 
biosynthesis of melanocyte-stimulating peptides, the solid circles show the $0-min 
pulse profile after incubation in the presence of 5 x  t0  -s M dopamine, while the 
open circles show the 30 min pulse-3 h chase profile in dopamine. The ordinates 
and abscissa are as described for Fig. 2. Neither the biosynthesis nor the processing 
mechanisms appear to be inhibited by dopamine. Note, however, that the products 
are  accumulated  in  the  tissue  in  the  presence of dopamine.  Each  of the  peaks 
marked by an asterisk (*) comigrated with melanotropic bioactivity (**>*). 
Thus  there  appears  to  be  a  rapid  release  of TCA-soluble  peptides  from  the 
tissue. 
As  with  the  TCA-precipitable  peptides,  the  TCA-soluble  peptide  release 
mechanism was also inhibited  by dopamine (5  x  10 -5 M). This is illustrated  in 
Fig. 9. In the control tissue, which was chased for 3 h  (open bars), 9.5%  --- 3.8% 
of total TCA-soluble incorporated radioactivity remained in the tissue, whereas 
in the presence of dopamine there was virtually no release from the tissue. 89.5% 
+_ 4% of the total TCA-soluble radioactivity was present in the control medium, LOH  AND  G^INzt  Melanoefopic  Pe#ti~ Biosynthesis and  Release  49 
whereas in the dopamine-treated tissue 2% -  0.5% of the TCA-soluble label was 
in the medium. Thus 5  x  10  -s M dopamine in the chase medium caused 98% +- 
0.5% inhibition of the release of TCA-soluble peptides. 
Analysis  of the Labeled  TCA-Soluble  Peptides Synthesized  and  Released  by  the 
Neurointermediate  Lobe 
The labeled TCA-soluble peptides were  fractionated into two groups  by G10 
Sephadex chromatography (see Materials and Methods). Bioassay for melano- 
tropic activity of extracts of neurointermediate lobes from white-adapted toads 
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pulse  labeling  in  [aH]arginine.  The  ordinate  shows the  TCA-soluble  cpm  (in 
peptides, see Materials and Methods)  as percent of the TCA-precipitable cpm in 
tissue  plus  medium.  This  was  used  as  a  method  to  normalize  the  data  from 
different experiments. The labeled TCA-soluble  peptides appear to be completely 
released by the tissue into the medium after about 1 h of chase. 
showed that only the excluded volume (Vr fraction) was melanotropic. There- 
fore, only the VE fraction (corresponding to molecular weights ->700 dahons) of 
the labeled TCA-soluble peptides was separated by thin-layer high-voltage elec- 
trophoresis at pH 4.9. Fig. 10 shows the labeling patterns on the thin-layer plate 
after electrophoresis of the  peptides  found in  lobes  after  a  30-min  pulse  in 
[3H]arginine (filled circles) and in medium after a 30-min chase (open circles). In 
both samples there was a single major labeled peak (7 cm from the origin), which 
comigrated with the only bioassayable melanotropic peak found in TCA-soluble 
extracts of lobes from white-adapted animals. Two minor peaks of radioactivity 
(at the origin and 4 cm from the origin) which did not have melanotropic activity 
were  also  observed.  Thus,  the  major  labeled  peak  which  has  an  Rf  of 0.78 
(relative to the mobility of methyl green on the plate) is both synthesized in the 50  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  -  VOLUME  70  •  1977 
tissue  and  released  into  the  medium.  This  labeled  peak  does  not correspond 
with either  a- or fl-MSH  which, in contrast,  are TCA  precipitable  and  have Rf 
values (on the cellulose  plates)  of 0.56 and 0.47,  respectively. 
Effect of Dopamine on the Biosynthesis of TCA-Soluble  Peptides 
Neurointermediate  lobes  were  preincubated  for  1  h  in  5  ×  10 -s  M  dopamine 
media and then pulsed in [3H]arginine  for 30 rain in the presence of dopamine. 
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FIGURE 9.  Bar graphs showing the effect of 5  x  10 -5 M dopamine on the release 
of [aH]arginine-labeled  TCA-soluble  peptides.  The control (open  bar)  shows that 
9.5%  ±  3.8% of the total TCA-soluble radioactivity remained in the tissue after 3 h 
of chase and 89.5%  ±  4.5%  was released into the medium. With dopamine in the 
medium during the 3-h chase (hatched bars) only 2%  ±  0.5%  was released into the 
medium. This represents a 98%  ±  0.5%  inhibition of release of the TCA-soluble 
peptides by dopamine. 
Comparison of the labeled TCA-soluble peptides (in the VE fraction) synthesized 
in the presence and absence of dopamine is shown in Fig.  11.  Separation of the 
control-pulsed  peptides  (Fig.  11,  filled circles) revealed  the typical  major mela- 
notropic  peak  (R~  =  0.78,  seen  also  in  Fig.  10 after  a  shorter  electrophoretic 
separation). After dopamine treatment (Fig.  11, open circles) the labeling profile 
was quite different.  The Rf 0.78  peak was greatly reduced,  whereas most of the Loll AND GAINER Melanotropic Peptide Biosynthesis and Release  51 
label appeared in a  nonmelanotropic Rf 0.26 peak. Therefore,  unlike the case 
with the TCA-precipitable  peptides, we cannot discount the possibility that the 
inhibition  of release  of the  TCA-soluble  peptides by dopamine  was due  to a 
modification of the biosynthesis mechanism (see Discussion). 
DISCUSSION 
Biosynthesis of Melanotropic Peptides 
Studies on the incorporation of [3H]Arginine into TCA-precipitable peptides in 
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FIGURE  10.  High-voltage  electrophoresis (pH 4.9, cellulose  thin-layer  plates)  of 
labeled TCA-soluble peptides. The ordinate shows the cpm/cm while the abscissa 
shows the distance the peptides migrated  from the origin (in centimeters).  After a 30- 
rain pulse, the tissue contained a dominant all-labeled peak which migrated 7 cm 
towards the cathode from the origin. Minor peaks were also observed at the origin 
and  4 cm from the origin.  After a  30-rain chase,  the  medium showed a  major 
labeled peak that also migrated 7 cm from the origin.  Bioassay studies of white- 
adapted  toads showed that  this  released peak contained  melanocyte-stimulating 
activity (denoted by *). 
the  neurointermediate  lobes from  dark-  vs.  white-adapted  toads  showed that 
lobes from dark.adapted animals had much higher incorporation rates (Fig.  1). 
Since it is well known that dark-adapting conditions cause profound changes in 
the morphology and increases in secretory activity of the neurointermediate lobe 
in vivo (Hopkins,  1970,  1972; Thornton,  1974; Terlou et al,  1974), it is perhaps 
not surprising that the biosynthetic activity of the lobe is changed as well. The 
shape of the incorporation  curve for the lobe from white-adapted animals  (see 
Fig. 1) is suggestive of an induction of biosynthetic activity with incubation time 
in vitro. Similar observations were made by Thornton (1974), although his initial 52  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  "  VOLUME  70  "  1977 
differences in incorporation (of [3H]leucine) into lobe  peptides  of white-  and 
dark-adapted  animals  were  not  as  dramatic  as  was  found  here  (Fig.  1).  This 
apparent induction in vitro may be related to the cessation of the hypothalamic 
inhibition of the lobe, normally occurring in vivo, when the neurointermediate 
lobe  is  dissected  for  incubation  in  vitro.  We  are  currently  investigating  this 
possibility. 
The nature of the newly synthesized TCA-precipitable peptides in lobes from 
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FIGUR~ l].  High-voltage  electrophoresis  (pH  4.9)  of labeled  TCA-solub]e  pep 
tides from neurointermediate lobes incubated for 30 min in [3H]arginine in the 
absence (filled circles)  and presence of 5 x  10  -5 M dopamine (open circles). The 
ordinate and abscissa are as described in Fig. 10, except that in this case, in order to 
increase resolution, a longer migration towards the cathode was employed. Note 
that in the absence of dopamine the major labeled peptide in the lobe migrated 12 
cm from the origin (Rt 0.78, relative to methyl green), whereas in the dopamine- 
treated tissue the major labeled peptide peak migrated 4 cm (R~ 0.26), with only a 
small peak at 12 cm. 
dark-adapted animals was analyzed by acid-urea polyacrylamide gel electropho- 
resis. Pulse incubations ranging from 5 to 30 rain (Fig. 2) revealed primarily one 
major labeled peak (peak a), with a molecular weight of 36,000 daltons (see Table 
I).  Pulse-chase experiments showed  that  peak a  decreased in time, as various 
new lower molecular weight peaks appeared (Fig. 3, Table I). Since there was no 
further  incorporation  of [3H]arginine  during  the  chase  (see  Fig.  1,  arginine 
chase curve), the  progressive appearance  of these lower  molecular weight  la- 
beled peaks during the chase is probably due to the post-translational processing 
(cleavage) of larger labeled precursors. Although peak a appears to be a precur- 
sor  of some  of th  e  processed  peptides,  it  is  difficult  to identify the  specific 
products  derived  from  peak  a  due  to  the  heterogeneity of the  peaks  seen. Loll  AND  GAINER  Melanotropic  Peptide  Biosynthesis and  Release  53 
Similarly,  peak b which is seen during the pulse but rapidly disappears during 
the  chase  may  also be  a  precursor  or  a  transient  intermediate  form.  In  this 
regard,  the  recent  report  by Mains  and  Eipper  (1976)  on  the  biosynthesis of 
ACTH in mouse pituitary tumor cells is of interest. These authors propose that a 
31,000 dalton ACTH is the biosynthetic precursor of the smaller forms of ACTH 
whose molecular weights are 23,000, 13,000, and 4,500. These molecular weights 
approximately correspond to the labeled peaks a, b, d,  and i synthesized in the 
total neurointermediate lobe (Table I). Other studies using mRNA-directed cell 
free protein synthesis systems have shown that large immunoreactive forms of 
ACTH  were  synthesized  with  molecular  weights  comparable  to  peak  a  (i.e. 
35,000 dalton  molecular weight in bovine anterior  pituitary,  Nakanishi  et al., 
1976; 31,000 dalton molecular weight in mouse pituitary tumor cells, Jones et al., 
1977).  Peaks k and l, which become labeled after prolonged chases (Fig. 3) and 
appear to have significantly higher molecular weights than peak a (on the basis of 
their low mobility on acid-urea gels and of preliminary  SDS gel analyses), also 
have significant melanotropic activity. Thus it is possible that they were derived 
from even larger labeled precursors which were not soluble in the 0.9 M acetic 
acid-5  M  urea  solution  used  to  dissolve  the  TCA  pellet  in  preparation  for 
electrophoresis. 
Comparisons of the Rt values on acid-urea gels, molecular weights, and mela- 
notropic potencies of the released labeled peptides with  standard  purified  (or 
synthetic)  melanotropic  peptides  (Table  I)  suggest  that  peak g  represents  /3- 
LPH, peak i is ACTH, and peakj is  a-MSH.  Definitive identification  of these 
labeled peaks must await the results of immunological experiments (in progress). 
Immunological evidence for the presence of "big ACTH" (Yalow and  Berson, 
1971) and  ACTHI-39  in  the  amphibian  neurointermediate  lobe  has  been  re- 
ported  (Estivariz  and  Iturriza,  1975).  If,  as  is  commonly  believed,  ACTH  is 
derived  from  the  cleavage  of  big  ACTH,  then  immunoprecipitates  of  the 
homogenates of pulsed lobes (using the Kendall and West antibodies to ACTH) 
should reveal labeled peptide species comparable in molecular properties to big 
ACTH  as  well as  ACTH  and  o~-MSH.  In  this  regard  it is interesting  that  we 
found  a  labelecl  peak  (peak g)  corresponding  in R~ (1.01)  to  /~-LPH,  but  no 
labeled peak corresponding to an Rf equal to  1.6 (i.e.  the Rt of/3-MSH). This 
finding is curious since/3-MSH has been reported, on the basis of high-voltage 
electrophoresis  separations  and  bioassay  analyses  (Burgers,  1963;  Hopkins, 
1972), to be in the amphibian neurointermediate lobe. We have found bioassaya- 
ble activity on acid-urea gels in the migration  position of/3-MSH (unpublished 
data),  but we could obtain  no evidence at all for biosynthesis of this  peptide. 
Since/3-MSH is presumed to be derived from the precursor/3-LPH (Scott et al., 
1973) which appears to be amply labeled in our experiments, the question must 
be raised of whether this conversion is a physiologically significant one in vivo. 
Bertagna et al. (1974) also failed to observe a conversion of/3-LPH to/3-MSH in 
pulse-chase experiments on sheep pituitaries, and/3-MSH could not be detected 
in  human  pituitary  (Silman  et  al.,  1976).  Whether  the  /3-MSH  previously re- 
ported in amphibian  neurointermediate  lobes was the result of in situ biosyn- 
thesis mechanisms or of the degradation of the/3-LPH during tissue preparation 
for analysis  requires  further  investigation.  It  should  be emphasized  that  the 54  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY'  VOLUME  70  •  1977 
dynamic state of the pars intermedia (i.e. the influence of the color adaptation of 
the animal)  and  the  heterogeneity of melanotropic peptides  synthesized and 
released makes analysis of the processing sequence in a  pulse-chase paradigm 
very difficult. The use of specific antibodies (e.g., for fl-LPH, ACTH, and cx- 
MSH) for immunoprecipitation of the labeled peptides after pulses and chases 
of various durations will be essential in future work. 
Analysis of the TCA-soluble peptides showed that bioassayable melanotropic 
activity was  found  only in  the  excluded  volume  (l/E)  of the  G10  Sephadex 
separation  (i.e.  VE  contains  peptides  with  molecular  weights  >700  daltons). 
Peptides extracted from a 30-min pulsed intermediate lobe and found in the VE 
were separated by high-voltage electrophoresis at pH 4.9. The synthesis of one 
dominant labeled  peak  which  was  released  to  the  medium  and  has  potent 
melanocyte-stimulating activity was detected (Fig. 10). This peak appears to be 
rapidly synthesized and released from the tissue with chase (Fig. 8). With a short 
pulse  of  15  min,  this  TCA-soluble  peptide  is  already  found  to  be  labeled 
(unpublished data). Whether its mode of synthesis is by cleavage of a precursor 
is unknown at present. 
Control of Melanotropic Peptide Release by Dopamine 
The relatively slow (tljz = 2 h) release of the newly synthesized TCA-precipitable 
peptides is consistent with their relatively slow processing times in the tissue. The 
relatively rapid  release (tit2 =  30  min) of the labeled TCA-soluble peptides is 
correlated  with  their rapid  synthesis.  Hopkins  (1970) showed that  maximum 
release  of bioassayable  melanotropic  peptides  from Xenopus  lobes  occurred 
between 2 and 6 h of incubation. This time course is comparable to that which we 
have found with the TCA-precipitable peptides. However, by using this biosyn- 
thetic paradigm we have found two independent release mechanisms: a  rapid 
one for the small TCA-soluble  peptide,  and a  slow  one for the larger TCA- 
precipitable peptides. 
The release of the TCA-precipitable and soluble peptides appears to be under 
inhibitory control by dopamine (Figs. 6 and 9).  Dopamine caused 72%  -  2.8% 
inhibition of release of TCA-precipitable peptides and 98% + 0.5% inhibition of 
TCA-soluble peptides. This dopamine effect was consistent with previous re- 
ports in the literature based on bioassay data (Hadley et al., 1973, 1975; Bower et 
al.,  1974). These  effects  of dopamine  to  inhibit  release  raised  the  issue  of 
whether dopamine acted via a  feedback inhibition of the biosynthesis and/or 
processing of the peptides. We found that neither the synthesis nor the process- 
ing of the TCA-precipitable  peptides was  affected by dopamine after  1 h  of 
pretreatment with dopamine in vitro (Fig. 7). Moreover, the inhibition of release 
allowed the accumulation of the releasable melanotrophic peptides in the tissue 
(Fig. 7). 
In  contrast  to  the  above  lack  of effect  on  the  TCA-precipitable  peptide 
biosynthesis by dopamine treatment of the lobe, the TCA-soluble peptide was 
profoundly affected (Fig. 11). Instead of the normal (Rf =  0.78) peak of labeled 
melanotropic peptide in the tissue after a 30-min pulse, a highly labeled nonme- 
lanotropic peak (Rf =  0.26) was found. We interpret these data not as an effect 
of dopamine upon synthesis, but rather as an enhancement of the degradation LOH AND GAINER Melanotropic Peptide Biosynthesis and Release  55 
of the R~ 0.78  peak to the Rf 0.26 peak in the lobe evoked by dopamine.  The 
reason for this interpretation is that we have observed a similar tendency for the 
labeled Rf 0.78 peak to be converted to the labeled Rr 0.26 peak in the media in 
long-term chase experiments in  the absence of dopamine  (unpublished  data), 
presumably  due  to  the  degradation  of the  release  peptide  with  time  in  the 
media.  If this interpretation is correct, then dopamine inhibition of release of 
the  TCA-soluble  peptide  may be  coupled  to an  enhancement  of degradative 
mechanisms in the tissue specifically directed at this peptide. Such a regulatory 
mechanism, if it indeed exists, would be particularly well suited to a biosynthesis 
and  release system which requires a  fast response to a  specific input.  That is, 
even  after  a  long-term  inhibition  of release  (as  is  the  case  in  vivo in  white- 
adapted animals), it would not require a  long induction period for the biosyn- 
thesis of the released peptide (as appears to be the case for the TCA-precipitable 
peptides) upon removal of'the inhibition. A  rapid decrease in the post-transla- 
tional  degradative  processes would  then be the  only requirement  for a  rapid 
response.  That this  system is in  fact operating in  the toad  neurointermediate 
lobe is speculative at present and experiments are currently in progress to test 
this notion. 
Possible  Physiological Significance  of the  Heterogeneous  Forms of Melanotropic 
Peptides 
In this work we have demonstrated that the neurointermediate lobe of the toad 
synthesizes and releases eight distinct melanotropic peptides. Do these different 
forms have distinct functional roles? We can only speculate about this issue  at 
this time. In the previous section we discussed the possibility that the presence of 
a  rapidly  synthesized  and  released  melanotropic  peptide  (under  degradative 
control) in combination with slowly synthesized and released melanotropic pep- 
tides  may provide effective control mechanism  for both short-term and  long- 
term adaptive color changes. In addition, the various peptides may be inactivated 
at different rates in the blood and thus may be used at different times depending 
upon the specific dark adaptation strategy employed by the animal.  We do not 
know whether all the melanotropic peptides are synthesized in and released by 
one cell type, or if each form is  under independent control in a  separate cell 
type.  The  latter  possibility  would,  of course,  be  a  more  efficacious form  of 
organization for the selective regulation mechanisms discussed above. 
In recent years, attention has been focused on the extramelanotropic action of 
peptides containing the heptapeptide sequence essential for melanocyte expan- 
sion. For example, ACTH, ACTH fragments (e.g., ACTH4--10), and ~-MSH can 
profoundly affect neuronal activity and behavior (De Wied et al., 1972; Sandman 
et ~1.,  1975;  Krivoy and  Guillemin,  1962).  Whether some  of the  melanotropic 
peptide forms found in the neurointermediate lobe of the toad are involved in 
the control of the nervous system remains to be determined. 
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